|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMGP08010003
|
PIP2[4',5'] 17:0/20:4(5Z,8Z,11Z,14Z)
|
1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-4',5'-bisphosphate)
|
PIP2 37:4
|
C46H83O19P3
|
1032.474143
|
|
LMGP20050018
|
PON-PI
|
1-hexadecanoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 25:1;O
|
C34H63O14P
|
726.395547
|
|
LMGP20050018
|
PON-PI
|
1-hexadecanoyl-2-(9-oxo-nonanoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 25:1;O
|
C34H63O14P
|
726.395547
|
|
LMGP20050035
|
OHODA-PI
|
1-(9Z-octadecenoyl)-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 30:3;O2
|
C39H69O15P
|
808.437412
|
|
LMGP20050035
|
OHODA-PI
|
1-(9Z-octadecenoyl)-2-(9-hydroxy-12-oxo-10E-dodecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 30:3;O2
|
C39H69O15P
|
808.437412
|
|
LMGP20050034
|
OKDdiA-PI
|
1-(9Z-octadecenoyl)-2-(9-oxo-11-carboxy-10E-undecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 30:4;O3
|
C39H67O16P
|
822.416677
|
|
LMGP20050034
|
OKDdiA-PI
|
1-(9Z-octadecenoyl)-2-(9-oxo-11-carboxy-10E-undecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 30:4;O3
|
C39H67O16P
|
822.416677
|
|
LMGP15010205
|
PIM5 17:0/18:1(9Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 35:1
|
C74H133O38P
|
1660.821258
|
|
LMGP20050015
|
PG-PI
|
1-hexadecanoyl-2-glutaryl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 22:1;O
|
C30H55O15P
|
686.327862
|
|
LMGP20050015
|
PG-PI
|
1-hexadecanoyl-2-glutaryl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 22:1;O
|
C30H55O15P
|
686.327862
|
|
LMGP15010208
|
PIM5 18:0/16:1(9Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 34:1
|
C73H131O38P
|
1646.805608
|
|
LMGP13010007
|
CDP-DG(16:0/18:2(9Z,12Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphinic acid
|
CDP-DG 34:2
|
C46H81N3O15P2
|
977.514294
|
|
LMGP13010009
|
CDP-DG(16:0/20:4(8Z,11Z,14Z,17Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-3-(hexadecanoyloxy)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy]phosphinic acid
|
CDP-DG 36:4
|
C48H81N3O15P2
|
1001.514294
|
|
LMGP13010012
|
CDP-DG(18:0/16:0
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid
|
CDP-DG 34:0
|
C46H85N3O15P2
|
981.545594
|
|
LMGP13010013
|
CDP-DG(18:0/18:0
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2,3-bis(octadecanoyloxy)propoxy]phosphinic acid
|
CDP-DG 36:0
|
C48H89N3O15P2
|
1009.576894
|
|
LMGP13010021
|
CDP-DG(18:1(11Z)/16:0
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2-(hexadecanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid
|
CDP-DG 34:1
|
C46H83N3O15P2
|
979.529944
|
|
LMGP13010023
|
CDP-DG(18:1(11Z)/18:1(9Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid
|
CDP-DG 36:2
|
C48H85N3O15P2
|
1005.545594
|
|
LMGP15010209
|
PIM5 18:0/16:2(9Z,12Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 34:2
|
C73H129O38P
|
1644.789958
|
|
LMGP15010215
|
PIM5 18:1(9Z)/16:2(9Z,12Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 34:3
|
C73H127O38P
|
1642.774308
|
|
LMGP13010025
|
CDP-DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propoxy]phosphinic acid
|
CDP-DG 38:5
|
C50H83N3O15P2
|
1027.529944
|
|
LMGP13010018
|
CDP-DG(18:0/20:4(8Z,11Z,14Z,17Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid
|
CDP-DG 38:4
|
C50H85N3O15P2
|
1029.545594
|
|
LMGP15010217
|
PIM5 18:1(9Z)/18:1(9Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 36:2
|
C75H133O38P
|
1672.821258
|
|
LMGP15010220
|
PIM5 18:2(9Z,12Z)/16:1(9Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 34:3
|
C73H127O38P
|
1642.774308
|
|
LMGP13010033
|
CDP-DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)
|
[({[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy][(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic acid
|
CDP-DG 38:5
|
C50H83N3O15P2
|
1027.529944
|
|
LMGP15040005
|
LPIM1(18:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 18:2
|
C33H59O17P
|
758.348992
|
|
LMGP15040002
|
LPIM1(17:0/0:0)
|
2'-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 17:0
|
C32H61O17P
|
748.364642
|
|
LMGP15040003
|
LPIM1(18:0/0:0)
|
2'-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 18:0
|
C33H63O17P
|
762.380292
|
|
LMGP15040004
|
LPIM1(18:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 18:1
|
C33H61O17P
|
760.364642
|
|
LMGP15040006
|
LPIM1(19:0/0:0)
|
2'-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 19:0
|
C34H65O17P
|
776.395942
|
|
LMGP15040008
|
LPIM1(19:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM1 19:2
|
C34H61O17P
|
772.364642
|
|
LMGP15040010
|
LPIM2(17:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM2 17:0
|
C38H71O22P
|
910.417467
|
|
LMGP15040011
|
LPIM2(18:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM2 18:0
|
C39H73O22P
|
924.433117
|
|
LMGP15040013
|
LPIM2(18:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM2 18:2
|
C39H69O22P
|
920.401817
|
|
LMGP15040014
|
LPIM2(19:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM2 19:0
|
C40H75O22P
|
938.448767
|
|
LMGP15040016
|
LPIM2(19:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM2 19:2
|
C40H71O22P
|
934.417467
|
|
LMGP15040018
|
LPIM3(17:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM3 17:0
|
C44H81O27P
|
1072.470292
|
|
LMGP15040019
|
LPIM3(18:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM3 18:0
|
C45H83O27P
|
1086.485942
|
|
LMGP15040020
|
LPIM3(18:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM3 18:1
|
C45H81O27P
|
1084.470292
|
|
LMGP15040023
|
LPIM3(19:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM3 19:1
|
C46H83O27P
|
1098.485942
|
|
LMGP15040025
|
LPIM4(16:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM4 16:0
|
C49H89O32P
|
1220.507467
|
|
LMGP15040027
|
LPIM4(18:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM4 18:0
|
C51H93O32P
|
1248.538767
|
|
LMGP15040033
|
LPIM5(16:0/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM5 16:0
|
C55H99O37P
|
1382.560293
|
|
LMGP15040037
|
LPIM5(18:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM5 18:2
|
C57H99O37P
|
1406.560293
|
|
LMGP15040039
|
LPIM5(19:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM5 19:1
|
C58H103O37P
|
1422.591593
|
|
LMGP15040029
|
LPIM4(18:2(9Z,12Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM4 18:2
|
C51H89O32P
|
1244.507467
|
|
LMGP15040031
|
LPIM4(19:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM4 19:1
|
C52H93O32P
|
1260.538767
|
|
LMGP15010221
|
PIM5 18:2(9Z,12Z)/16:2(9Z,12Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 34:4
|
C73H125O38P
|
1640.758658
|
|
LMGP15040047
|
LPIM6(19:1(9Z)/0:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
LPIM6 19:1
|
C64H113O42P
|
1584.644418
|
|
LMGP15010246
|
PIM6(16:0/18:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM6 34:0
|
C79H143O43P
|
1810.874083
|
|
LMGP15010248
|
PIM6(17:0/14:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM6 31:0
|
C76H137O43P
|
1768.827133
|